Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
3.105
+0.095 (3.16%)
Apr 2, 2026, 5:35 PM CET

Cellectis Revenue

In the year 2025, Cellectis had annual revenue of $79.59M USD with 61.72% growth. Cellectis had revenue of $12.21M in the quarter ending December 31, 2025, a decrease of -19.51%.

Revenue
$79.59M
Revenue Growth
+61.72%
P/S Ratio
3.32
Revenue / Employee
$347.57K
Employees
229
Market Cap
225.40M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE174.66M
Genfit45.13M
MedinCell32.44M
Adocia12.88M
Innate Pharma9.01M
Transgene7.21M
Sensorion5.81M
ABIONYX Pharma4.10M
Revenue Rankings